DK1441723T3 - Anvendelse af irbesartan til fremstilling af lægemidler til forebyggelse eller behandling af pulmonal hypertension - Google Patents

Anvendelse af irbesartan til fremstilling af lægemidler til forebyggelse eller behandling af pulmonal hypertension

Info

Publication number
DK1441723T3
DK1441723T3 DK02785535T DK02785535T DK1441723T3 DK 1441723 T3 DK1441723 T3 DK 1441723T3 DK 02785535 T DK02785535 T DK 02785535T DK 02785535 T DK02785535 T DK 02785535T DK 1441723 T3 DK1441723 T3 DK 1441723T3
Authority
DK
Denmark
Prior art keywords
irbesartan
drugs
prevention
manufacture
treatment
Prior art date
Application number
DK02785535T
Other languages
Danish (da)
English (en)
Inventor
Sylvie Cosnier-Pucheu
Dino Nisato
Alain Roccon
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK1441723T3 publication Critical patent/DK1441723T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DK02785535T 2001-10-26 2002-10-09 Anvendelse af irbesartan til fremstilling af lægemidler til forebyggelse eller behandling af pulmonal hypertension DK1441723T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0113936A FR2831446B1 (fr) 2001-10-26 2001-10-26 Utilisation de l'irbesartan pour la preparation de medicaments utiles pour la prevention ou le traitement de l'hypertension pulmonaire
PCT/FR2002/003439 WO2003035062A1 (fr) 2001-10-26 2002-10-09 Utilisation de l'irbesartan pour la preparation de medicaments utiles pour la prevention ou le traitement de l'hypertension pulmonaire

Publications (1)

Publication Number Publication Date
DK1441723T3 true DK1441723T3 (da) 2007-09-10

Family

ID=8868812

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02785535T DK1441723T3 (da) 2001-10-26 2002-10-09 Anvendelse af irbesartan til fremstilling af lægemidler til forebyggelse eller behandling af pulmonal hypertension

Country Status (24)

Country Link
US (2) US20040242567A1 (es)
EP (1) EP1441723B1 (es)
JP (1) JP4542777B2 (es)
CN (1) CN100418526C (es)
AT (1) ATE361071T1 (es)
AU (1) AU2002350832B2 (es)
BR (1) BR0213479A (es)
CA (1) CA2461625C (es)
CY (1) CY1106746T1 (es)
DE (1) DE60219940T2 (es)
DK (1) DK1441723T3 (es)
EA (1) EA007952B1 (es)
ES (1) ES2286304T3 (es)
FR (1) FR2831446B1 (es)
HU (1) HUP0401633A3 (es)
IL (2) IL161116A0 (es)
IS (1) IS2849B (es)
MX (1) MXPA04003910A (es)
NO (1) NO332313B1 (es)
NZ (1) NZ532130A (es)
PL (1) PL209263B1 (es)
PT (1) PT1441723E (es)
WO (1) WO2003035062A1 (es)
ZA (1) ZA200402696B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
TR200301553A1 (tr) * 2003-09-18 2005-10-21 Nobel �La� Sanay�� Ve T�Caret A.�. İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
ATE493973T1 (de) 2004-06-04 2011-01-15 Teva Pharma Irbesartan enthaltende pharmazeutische zusammensetzung
WO2006067601A1 (en) * 2004-12-23 2006-06-29 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of irbesartan and hydrochlorothiazide and processes for their preparation
CN100367959C (zh) * 2006-08-29 2008-02-13 陈俊云 一种含有依贝沙坦的药物
GB0617171D0 (en) * 2006-08-31 2006-10-11 Generics Uk Ltd Novel compositions and methods
JP2024510446A (ja) * 2021-03-23 2024-03-07 ダイメリックス バイオサイエンス ピーティーワイ リミテッド 炎症性疾患の処置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
NZ237476A (en) * 1990-03-20 1994-01-26 Sanofi Sa N-substituted heterocyclic compounds and pharmaceutical compositions.
US5270317A (en) * 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
RU2086544C1 (ru) * 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
US5292741A (en) * 1992-08-18 1994-03-08 Merck & Co., Inc. Macrocycles incorporating quinazolinones
EP1106210A3 (en) 1999-12-07 2003-12-03 Pfizer Products Inc. Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications

Also Published As

Publication number Publication date
MXPA04003910A (es) 2004-07-23
JP4542777B2 (ja) 2010-09-15
PT1441723E (pt) 2007-07-26
US20040242567A1 (en) 2004-12-02
EA007952B1 (ru) 2007-02-27
FR2831446B1 (fr) 2004-03-05
CA2461625A1 (en) 2003-05-01
IL161116A (en) 2010-12-30
PL368737A1 (en) 2005-04-04
AU2002350832B2 (en) 2006-11-30
NO20041732L (no) 2004-07-23
EP1441723B1 (fr) 2007-05-02
US8088827B2 (en) 2012-01-03
EP1441723A1 (fr) 2004-08-04
CN100418526C (zh) 2008-09-17
ES2286304T3 (es) 2007-12-01
DE60219940D1 (de) 2007-06-14
DE60219940T2 (de) 2008-01-17
CY1106746T1 (el) 2012-05-23
NO332313B1 (no) 2012-08-27
FR2831446A1 (fr) 2003-05-02
NZ532130A (en) 2006-10-27
EA200400438A1 (ru) 2004-10-28
ATE361071T1 (de) 2007-05-15
US20090247510A1 (en) 2009-10-01
JP2005506369A (ja) 2005-03-03
PL209263B1 (pl) 2011-08-31
CN1610548A (zh) 2005-04-27
BR0213479A (pt) 2004-11-03
WO2003035062A1 (fr) 2003-05-01
HUP0401633A2 (hu) 2004-12-28
IS7200A (is) 2004-03-29
HUP0401633A3 (en) 2009-06-29
IL161116A0 (en) 2004-08-31
IS2849B (is) 2013-09-15
ZA200402696B (en) 2005-06-29
CA2461625C (en) 2011-07-05

Similar Documents

Publication Publication Date Title
NO20071343L (no) Substituerte fenylaminotiazoler og anvendelse derav
NO20062767L (no) Immunoglobuliner
CY1110965T1 (el) Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου
NO20052626D0 (no) Middel for forhindring eller behandling av neuropati
NO20052739L (no) CCR5-antagonister som medikamenter
IS2855B (is) 4-anilínókínasólínafleiður sem andfjölgunarefni
NO20070049L (no) Pyrrolotriazinderivater anvendelig for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogenese
NO20072461L (no) Fremstilling og anvendelse av bifenyl-4-yl-karbonylaminosyre derivater for behandling av fedme
ATE551059T1 (de) Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie
ATE405269T1 (de) Cyclohexylverbindungen als ccr5-antagonisten
DK1789398T3 (da) 2-amino-quinazolin derivater anvendelige som inhibitorer af B-sekretase (BACE)
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
NO20030411D0 (no) Farmasöytiske sammensetninger for behandlingen av smertefulle, inflammatoriske og ulceröse tilstander av fuktige epiteloverflater slik sommukositt, stomatitt og Behcets syndrom
EP1858520A4 (en) CALCIUM CHANNEL ANTAGONISTS TYPE CHINAZOLINONE T
DE60322423D1 (de) Pyrrolidin- und azetidinverbindungen alsccr5-antagonisten
CY1106746T1 (el) Χρηση του irbesartan για την προληψη ή τη θεραπεια της πνευμονικης υπερτασης
DE60132851D1 (de) Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension
NO20076405L (no) Anvendelse av 24-nor-UDCA
DK1843771T3 (da) Anvendelse af pyrimidylaminobenzamider til behandling af sygdomme, der responderer på modulation af Tie-2-kinase-aktiviteten
NO20076663L (no) Immunoglobuliner
CY1110043T1 (el) 2-αμινοβενζουλ παραγωγα
AU2002350832A1 (en) Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension
WO2004055001A3 (en) Rabeprazole calcium
DK1503764T3 (da) 5-HT4-receptor-antagonister til behandling af hjertesvigt
DK1425007T3 (da) Anvendelse af C2-substituerede indan-1-ol-systemer til fremstilling af medikamenter til profylaxe eller behandling af obesitas